{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:16Z","timestamp":1787772436595,"version":"build-2784847793"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Drug information can be obtained from various drug information sources that were available as government (National Formulary of India [NFI]; Central Drugs Standard Control Organization [CDSCO]), as well as commercial documents (Current Index of Medical Specialties [CIMS] and Monthly Index of Medical Specialties [MIMS]). Irrational drug usage may happen due to wide variation in the information available in these sources. In this study, we tried to assess these variations in a sample of drugs for the acute-specific management of migraine with ergot and Triptans antimigraine drugs in drug information sources such as NFI, CIMS, MIMS, and CDSCO. Scoring was done for various drug information based on the completeness of information about drugs used in acute-specific management of migraine. The scores for the completeness of drug information about the selected antimigraine drugs are 18.37% for CIMS (Ergotamine, Sumatriptan, Rizatriptan, and Zolmitriptan), 21.1% for NFI (Dihydroergotamine, Sumatriptan), 72.79% for MIMS (Ergotamine tartrate, Sumatriptan, Rizatriptan, Naratriptan, zolmitriptan, Almotriptan) and 21.77% for CDSCO (Ergotamine tartrate, Sumatriptan, Rizatriptan, Naratriptan, Zolmitriptan, eletriptan and almotriptan). The information for the antimigraine drugs available from various sources found to so much deficient. Necessary steps need to be taken in case of government public or hard documents to streamline drug information available with them as well the commercial documents as to provide reliable drug information uniformly for promoting rational use of the drug.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_783_20","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:51:03Z","timestamp":1716479463000},"page":"216-220","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Information on migraine drugs in commonly available Indian drug information sources \u2013 Whether we satisfied the community needs?"],"prefix":"10.4103","volume":"54","author":[{"given":"Pugazhenthan","family":"Thangaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kothapalli","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajitha","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240903","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40267-019-00664-2","article-title":"Recent and updated pharmacotherapy of migraine","volume":"35","author":"Alok","year":"2019","journal-title":"Drugs Ther Perspect"},{"key":"R2-9-20240903","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0976-9668.175098","article-title":"Difference in described indications of medicines among drug information sources in India: An issue urgently to be addressed","volume":"7","author":"Singh","year":"2016","journal-title":"J Nat Sci Biol Med"},{"key":"R3-9-20240903","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s002280000217","article-title":"Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed","volume":"56","author":"Figueiras","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R4-9-20240903","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/009286159803200318","article-title":"Drug information sources: Reported preferences by general practitioners","volume":"32","author":"Lundborg","year":"1998","journal-title":"Drug Inf J"},{"key":"R6-9-20240903","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","article-title":"Off-label prescribing among office-based physicians","volume":"166","author":"Radley","year":"2006","journal-title":"Arch Intern Med"},{"key":"R9-9-20240903","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2710.2008.01005.x","article-title":"Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature","volume":"34","author":"Lindell-Osuagwu","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"R12-9-20240903","first-page":"S27","article-title":"Analysis of information provided in drug package inserts in India","volume":"43","author":"Pujari","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"R13-9-20240903","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0022-3859.52840","article-title":"Clinical information in drug package inserts in India","volume":"55","author":"Shivkar","year":"2009","journal-title":"J Postgrad Med"},{"key":"R14-9-20240903","first-page":"502","article-title":"Package inserts and the standard of care","volume":"16","author":"Thornton","year":"2003","journal-title":"Proc (Bayl Univ Med Cent"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_783_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:49Z","timestamp":1787770009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_783_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_783_20","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}